Stay updated on Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; there are no changes to the study details, eligibility criteria, outcomes, or other user-facing content.
    Difference
    0.1%
    Check dated 2025-12-01T15:53:23.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; no study details or page content were modified.
    Difference
    0.1%
    Check dated 2025-11-24T13:15:38.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The government funding status notice banner has been removed from the page. This change does not affect the study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:26:47.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    No substantive changes detected on the Study Details page for NCT03650894. The information and layout appear unchanged from the prior state.
    Difference
    0.5%
    Check dated 2025-11-03T01:06:36.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the old v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T09:46:20.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:06:20.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.